Relmada Therapeutics Inc

NASDAQ:RLMD  
18.62
-0.15 (-0.80%)
Equity Financing / Related, Initial Public Offerings

Relmada Therapeutics Announces Proposed Public Offering Of Common Stock

Published: 12/08/2021 21:30 GMT
Relmada Therapeutics Inc (RLMD) - Relmada Therapeutics Announces Proposed Public Offering of Common Stock.
Relmada Therapeutics Inc - Announced Its Intention to Offer and Sell $100 Million of Shares of Its Common Stock in an Underwritten Public Offering.
Relmada - Intends to Grant Underwriters 30-day Option to Purchase Up to Additional 15% of Shares of Common Stock Offered in Public Offering.